Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)

Foresee Pharmaceuticals Revenue

Foresee Pharmaceuticals had revenue of 156.95M TWD in the quarter ending September 30, 2025, with 95.94% growth. This brings the company's revenue in the last twelve months to 519.61M, up 49.93% year-over-year. In the year 2024, Foresee Pharmaceuticals had annual revenue of 418.69M with 114.67% growth.

• Revenue (ttm): 519.61M
• Revenue Growth: +49.93%
• P/S Ratio: 24.01
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 12.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	418.69M	223.65M	114.67%
Dec 31, 2023	195.04M	-106.47M	-35.31%
Dec 31, 2022	301.51M	75.48M	33.39%
Dec 31, 2021	226.03M	-4.41M	-1.91%
Dec 31, 2020	230.44M	155.24M	206.44%